BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 5558651)

  • 1. Ultracentrifugal demonstration of floating beta lipoproteins in type 3 hyperlipoproteinemia. Diagnostic value.
    Aubry F; Lapierre YL; Noël C; Davignon J
    Ann Intern Med; 1971 Aug; 75(2):231-7. PubMed ID: 5558651
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of a new drug MK 185 with clofibrate in the treatment of hyperlipidaemias.
    Jepson EM; Small E; Grayson MF; Bance G; Billimoria JD
    Atherosclerosis; 1972; 16(1):9-14. PubMed ID: 4341723
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
    Patsch JR; Yeshurun D; Jackson RL; Gotto AM
    Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of hypercholesterolaemia with colestipol: a bile sequestrating agent.
    Nye ER; Jackson D; Hunter JD
    N Z Med J; 1972 Jul; 76(482):12-6. PubMed ID: 4344110
    [No Abstract]   [Full Text] [Related]  

  • 5. Dietary and drug treatment of primary hyperlipoproteinemia.
    Ann Intern Med; 1972 Aug; 77(2):267-94. PubMed ID: 4345081
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver scan in hyperlipoproteinemia.
    Sachs BA; Bardfeld PA; Bodian JE; Sugarman LA; Hellman L
    JAMA; 1974 Feb; 227(8):907-10. PubMed ID: 4590252
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterogeneity on familial hyperlipoproteinemia type II on the basis of fasting plasma triglyceride-cholesterol ratio and plasma cholesterol response to ethyl p-chlorophenoxyisobutyrate.
    Davignon J; Aubry F; Noël C; Lapierre Y; Lafortune M
    Rev Can Biol; 1971 Dec; 30(4):307-18. PubMed ID: 5135408
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma lipoproteins and hyperlipoproteinemia.
    Gustafson A; Berg K
    Acta Med Scand; 1973 May; 193(5):369-72. PubMed ID: 4352670
    [No Abstract]   [Full Text] [Related]  

  • 9. Trial of an anabolic steroid (oxymetholone) in atherosclerosis with hyperlipoproteinaemia.
    Barton GM; Gillam PM; Longridge RG; Freeman PR
    Atherosclerosis; 1973; 18(3):505-7. PubMed ID: 4356387
    [No Abstract]   [Full Text] [Related]  

  • 10. Classification of lipoproteins and lipoprotein disorders.
    Lewis B
    J Clin Pathol Suppl (Assoc Clin Pathol); 1973; 5():26-31. PubMed ID: 4354845
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin.
    Glueck CJ; Tsang RC; Fallat RW; Scheel D
    Pediatrics; 1974 Jul; 54(1):51-5. PubMed ID: 4365953
    [No Abstract]   [Full Text] [Related]  

  • 12. On a family with coexistence of phenotypes II and III hyperlipoproteinemia.
    Mariën KJ; Hulsmans HA; van Gent CM
    Acta Med Scand; 1974 Sep; 196(3):149-53. PubMed ID: 4370577
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative study of several hypolipidemic agents related to clofibrate.
    Beaumont V; Buxtorf JC; Jacotot B; Beaumont JL
    Atherosclerosis; 1974; 20(2):141-53. PubMed ID: 4369878
    [No Abstract]   [Full Text] [Related]  

  • 14. The lipoprotein pattern in a Danish family. Preliminary report.
    Strunge P; Trostmann AF
    Acta Med Scand; 1971; 189(1-2):73-8. PubMed ID: 5121534
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of hyperlipidemia in the HGH-deficient state.
    Merimee TJ; Hollander W; Fineberg SE
    Metabolism; 1972 Nov; 21(11):1053-61. PubMed ID: 4342932
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypolipidemic drugs and hyperlipoproteinemia.
    Levy RI; Langer T
    Ann N Y Acad Sci; 1971 Jul; 179():475-80. PubMed ID: 4941915
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholestyramine in type II hyperlipoproteinemia. A double-blind trial.
    Levy RI; Fredrickson DS; Stone NJ; Bilheimer DW; Brown WV; Glueck CJ; Gotto AM; Herbert PN; Kwiterovich PO; Langer T; LaRosa J; Lux SE; Rider AK; Shulman RS; Sloan HR
    Ann Intern Med; 1973 Jul; 79(1):51-8. PubMed ID: 4578640
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of the combination of nicotinic acid and propranolol in very low doses on blood lipids in man.
    Avogaro P; Capri C; Cazzolato G; Pais M; Trabuio GF
    Atherosclerosis; 1974; 20(2):395-400. PubMed ID: 4369975
    [No Abstract]   [Full Text] [Related]  

  • 19. Ultracentrifugal analysis of lipoproteins during adaptation to high carbohydrate diet in type II hyperlipoproteinemia and normals.
    Blankenhorn DH; Lindgren FT; Jensen J; Jensen LC
    Proc Soc Exp Biol Med; 1972 Feb; 139(2):641-6. PubMed ID: 5059058
    [No Abstract]   [Full Text] [Related]  

  • 20. Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia.
    Miettinen TA; Penttilä IM; Lampainen E
    Acta Med Scand; 1972 Sep; 192(3):177-82. PubMed ID: 4341290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.